WSJ’s blog on health and the business of health. Eli Lilly looks to be following Pfizer off the sinking inhaled-insulin ship. Lilly’s partner, Alkermes, put out an unusual, pre-emptive press release saying it expects Lilly to discontinue the program ...
A spate of high-profile problems on the high seas, hurricane fears and weak demand for Caribbean sailings are leading cruise companies to offer fire-sale discounts in an effort to lure leery consumers aboard. The problems are combining to ...
Help us add to our database, by linking this writer their entry in Wikipedia or Source Watch, or by suggesting that we remove it from our index.